News | March 16, 2022
Bharat Biotech and Biofabri to develop and distribute novel TB vaccine
MTBVAC is a global public-private project that will be a milestone in the field of vaccinology
MTBVAC is a global public-private project that will be a milestone in the field of vaccinology
He has over 25 years of rich experience in marketing and business in various sectors
SIFI is currently evaluating various options for the commercialization of Akantior (polihexanide) globally, including potential out-license agreements outside its core markets
The focus is to build collaborative learning and sharing ecosystem
The new solution, built on patented blockchain technology, dynamically adapts to patients' behaviour patterns to make clinical encounters more effective
It is only the second generic application approved by the USFDA
Novartis data again demonstrate age-appropriate development when Zolgensma is used presymptomatically, and post-hoc data reveal SMA Type 1 patients could speak, swallow and maintain airway protection
Feedback and remarks of the industry and stakeholders are invited till the 25th of March 2022
Its technology-centric solutions enable hospitals to enhance operational efficiency and enable faster clinical decision making
Ritika has also extensively worked with clients such as WHO, GAVI Alliance, USAID, Gilead, Novartis, Sanofi Pasteur
Subscribe To Our Newsletter & Stay Updated
